APN01 Case Study Global BC 9.24.20 from status covid 19 Watch Video
Preview(s):
Gallery
Play Video: (Note: The default playback of the video is HD VERSION. If your browser is buffering the video slowly, please play the REGULAR MP4 VERSION or Open The Video below for better experience. Thank you!)
Description: Linda Aylesworth of Global TV BC interviews Life Sciences Institute Director Dr. Josef Penninger about the first human evidence supporting the use of APN01, the trial drug shown to block the gateway to the SARS-COV-2 receptor in cells. nnDr. Penninger describes the compassionate use of a therapeutic form of APN01 to treat a 45-year-old woman hospitalized with severe COVID-19, and the documentation of multiple indicators of improvement in her health status. Results of the patient's treatment as p
Play Video: (Note: The default playback of the video is HD VERSION. If your browser is buffering the video slowly, please play the REGULAR MP4 VERSION or Open The Video below for better experience. Thank you!)